Symbol="FRLN"
AssetType="Common Stock"
Name="Freeline TherapeuticsÂ Holdings Plc"
Description="Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops vector-mediated adeno-associated virus (AAV) transforming gene therapies for patients suffering from inherited systemic debilitating diseases. The company is headquartered in Stevenage, the United Kingdom."
CIK="1810031"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="STEVENAGE BIOSCIENCE CATALYST, GUNNELS WOOD ROAD, STEVENAGE, HERTFORDSHIRE, GB"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="17584400"
EBITDA="-75692000"
PERatio="None"
PEGRatio="None"
BookValue="9.64"
DividendPerShare="0"
DividendYield="0"
EPS="-11.11"
RevenuePerShareTTM="0.142"
ProfitMargin="0"
OperatingMarginTTM="-125.07"
ReturnOnAssetsTTM="-0.429"
ReturnOnEquityTTM="-0.801"
RevenueTTM="617000"
GrossProfitTTM="0"
DilutedEPSTTM="-11.11"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="12.8"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.559"
EVToRevenue="-"
EVToEBITDA="0.146"
Beta="0.707"
num_52WeekHigh="14.05"
num_52WeekLow="2.11"
num_50DayMovingAverage="3.747"
num_200DayMovingAverage="6.06"
SharesOutstanding="4358000"
DividendDate="None"
ExDividendDate="None"
symbol="FRLN"
open="4.00"
high="4.38"
low="3.97"
price="4.04"
volume="40842.00"
latest_trading_day="2023-08-25"
previous_close="4.06"
change="-0.03"
change_percent="-0.6158%"
aroon_positive_momentum_days="33"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="33"
Volume_recent_avg="325382"
Change_recent_avg="0.01"
Delta_recent_avg="0.38"
Variance_recent_avg="0.19"
Change_ratio_recent_avg="-1.36"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="33"
Aroon_momentum_negative="67"
image_negative_thumbnail_id_1="167"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0009.jpeg"
image_negative_thumbnail_id_2="1088"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0121.jpeg"
image_neutral_thumbnail_id_1="580"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0019.jpeg"
image_neutral_thumbnail_id_2="588"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0011.jpeg"
image_positive_thumbnail_id_1="662"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0046.jpeg"
image_positive_thumbnail_id_2="674"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0034.jpeg"
image_professor_thumbnail_id_1="1197"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
image_professor_thumbnail_id_2="1193"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
